Detailed Information

Cited 4 time in webofscience Cited 5 time in scopus
Metadata Downloads

Cognitive trajectories of patients with focal ß-amyloid deposition

Authors
Kim, Si EunLee, ByungjuJang, HyeminChin, JuheeKhoo, Ching SoongChoe, Yeong SimKim, Ji SunKang, Sung HoonKim, Hang-RaiHwangbo, SongJeong, Jee HyangYoon, Soo JinPark, Kyung WonKim, Eun-JooYoon, BoraJang, Jae-WonHong, Jin YongNa, Duk L.Seo, Sang WonChoi, Seong HyeKim, Hee Jin
Issue Date
19-Feb-2021
Publisher
BioMed Central Ltd
Keywords
18F-flutemetamol PET; Alzheimer’s disease; Cognitive decline; Longitudinal studies; ß-Amyloid
Citation
Alzheimer's Research and Therapy, v.13, no.1
Indexed
SCIE
SCOPUS
Journal Title
Alzheimer's Research and Therapy
Volume
13
Number
1
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/52314
DOI
10.1186/s13195-021-00787-7
ISSN
1758-9193
1758-9193
Abstract
Background: The presence of ß-amyloid (Aß) in the brain can be identified using amyloid PET. In clinical practice, the amyloid PET is interpreted based on dichotomous visual rating, which renders focal Aß accumulation be read as positive for Aß. However, the prognosis of patients with focal Aß deposition is not well established. Thus, we investigated cognitive trajectories of patients with focal Aß deposition. Methods: We followed up 240 participants (112 cognitively unimpaired [CU], 78 amnestic mild cognitive impairment [aMCI], and 50 Alzheimer’s disease (AD) dementia [ADD]) for 2 years from 9 referral centers in South Korea. Participants were assessed with neuropsychological tests and 18F-flutemetamol (FMM) positron emission tomography (PET). Ten regions (frontal, precuneus/posterior cingulate (PPC), lateral temporal, parietal, and striatum of each hemisphere) were visually examined in the FMM scan, and participants were divided into three groups: No-FMM, Focal-FMM (FMM uptake in 1–9 regions), and Diffuse-FMM. We used mixed-effects model to investigate the speed of cognitive decline in the Focal-FMM group according to the cognitive level, extent, and location of Aß involvement, in comparison with the No- or Diffuse-FMM group. Results: Forty-five of 240 (18.8%) individuals were categorized as Focal-FMM. The rate of cognitive decline in the Focal-FMM group was faster than the No-FMM group (especially in the CU and aMCI stage) and slower than the Diffuse-FMM group (in particular in the CU stage). Within the Focal-FMM group, participants with FMM uptake to a larger extent (7–9 regions) showed faster cognitive decline compared to those with uptake to a smaller extent (1–3 or 4–6 regions). The Focal-FMM group was found to have faster cognitive decline in comparison with the No-FMM when there was uptake in the PPC, striatum, and frontal cortex. Conclusions: When predicting cognitive decline of patients with focal Aß deposition, the patients’ cognitive level, extent, and location of the focal involvement are important. © 2021, The Author(s).
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Neurology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kang, Sung Hoon photo

Kang, Sung Hoon
Guro Hospital (Department of Neurology, Guro Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE